医药-话题@MedSci

#医药#

1668篇内容 | 2761人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1409785, encodeId=61fa1409e854f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2018年我国医药产品遭遇多起贸易摩擦, objectType=article, longId=158699, objectId=c396158699aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c396158699aa, replyNumber=0, likeNumber=74, createdTime=2019-01-25, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c396158699aa, moduleTitle=2018年我国医药产品遭遇多起贸易摩擦, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c396158699aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409784, encodeId=6cc11409e8439, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=国内医药巨头率先改革：下属代理商必须财税合规！, objectType=article, longId=158696, objectId=8c88158696f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c88158696f6, replyNumber=0, likeNumber=56, createdTime=2019-01-25, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c88158696f6, moduleTitle=国内医药巨头率先改革：下属代理商必须财税合规！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c88158696f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409783, encodeId=d4261409e83a6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=医药健康类自媒体不能长“獠牙”, objectType=article, longId=158638, objectId=bb7e15863890, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb7e15863890, replyNumber=0, likeNumber=64, createdTime=2019-01-24, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb7e15863890, moduleTitle=医药健康类自媒体不能长“獠牙”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb7e15863890)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409782, encodeId=3b6f1409e8274, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=保健品制售乱象后的医药中间体界定难题：致非法添加成潜规则, objectType=article, longId=158597, objectId=ee5a15859e82, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee5a15859e82, replyNumber=0, likeNumber=58, createdTime=2019-01-23, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee5a15859e82, moduleTitle=保健品制售乱象后的医药中间体界定难题：致非法添加成潜规则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee5a15859e82)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409781, encodeId=d1cd1409e816b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=盘点 | 2018年我国中医药重点产业政策, objectType=article, longId=158568, objectId=4a75158568fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a75158568fb, replyNumber=0, likeNumber=61, createdTime=2019-01-23, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a75158568fb, moduleTitle=盘点 | 2018年我国中医药重点产业政策, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a75158568fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409780, encodeId=8e131409e8098, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=“带量采购”搅动医药市场：冲击惯常销售模式，药价或大幅降, objectType=article, longId=158460, objectId=573015846066, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=573015846066, replyNumber=0, likeNumber=69, createdTime=2019-01-21, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=573015846066, moduleTitle=“带量采购”搅动医药市场：冲击惯常销售模式，药价或大幅降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=573015846066)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409779, encodeId=168e1409e79b5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=60%老医药代表，已转行, objectType=article, longId=158095, objectId=5c35158095dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c35158095dd, replyNumber=0, likeNumber=50, createdTime=2019-01-17, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c35158095dd, moduleTitle=60%老医药代表，已转行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c35158095dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409778, encodeId=bc741409e7828, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=医药企业2018年政府补贴哪家强？, objectType=article, longId=158044, objectId=6118158044e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6118158044e5, replyNumber=0, likeNumber=67, createdTime=2019-01-16, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6118158044e5, moduleTitle=医药企业2018年政府补贴哪家强？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6118158044e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409777, encodeId=49c11409e7726, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=为人民健康谋福祉医药改革让百姓更有获得感, objectType=article, longId=158023, objectId=10231580230c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10231580230c, replyNumber=0, likeNumber=61, createdTime=2019-01-16, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10231580230c, moduleTitle=为人民健康谋福祉医药改革让百姓更有获得感, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10231580230c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409776, encodeId=30b91409e76bb, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=卫健委谈2019年工作：将推动中医药振兴发展, objectType=article, longId=157901, objectId=996615e90162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=996615e90162, replyNumber=0, likeNumber=72, createdTime=2019-01-13, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=996615e90162, moduleTitle=卫健委谈2019年工作：将推动中医药振兴发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=996615e90162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409775, encodeId=f8b81409e75e1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=亚盛医药多个核心品种获“十三五”国家“重大新药创制”科技重大专项支持, objectType=article, longId=157896, objectId=ae9915e896a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae9915e896a3, replyNumber=0, likeNumber=90, createdTime=2019-01-13, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae9915e896a3, moduleTitle=亚盛医药多个核心品种获“十三五”国家“重大新药创制”科技重大专项支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae9915e896a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409774, encodeId=a32f1409e74c4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2018年度国家科学技术奖揭晓医药卫生领域硕果累累, objectType=article, longId=157810, objectId=9ec315e8105a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ec315e8105a, replyNumber=0, likeNumber=60, createdTime=2019-01-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ec315e8105a, moduleTitle=2018年度国家科学技术奖揭晓医药卫生领域硕果累累, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ec315e8105a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409773, encodeId=9a051409e73f2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=和铂医药任命Atul Deshpande博士为首席战略官兼美国运营负责人, objectType=article, longId=157427, objectId=d7fb15e427d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7fb15e427d7, replyNumber=0, likeNumber=97, createdTime=2019-01-08, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7fb15e427d7, moduleTitle=和铂医药任命Atul Deshpande博士为首席战略官兼美国运营负责人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7fb15e427d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409772, encodeId=dd0f1409e72db, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=荐读｜扑尔敏原料药企业实施垄断行为被处罚1243万元！医药代表备案制来了！, objectType=article, longId=157344, objectId=e60b15e34438, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e60b15e34438, replyNumber=0, likeNumber=53, createdTime=2019-01-06, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e60b15e34438, moduleTitle=荐读｜扑尔敏原料药企业实施垄断行为被处罚1243万元！医药代表备案制来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e60b15e34438)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409771, encodeId=7b6a1409e71c2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=上海自贸区：医药研发企业的“靶向药”, objectType=article, longId=157303, objectId=0ebb15e3037c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ebb15e3037c, replyNumber=0, likeNumber=75, createdTime=2019-01-06, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ebb15e3037c, moduleTitle=上海自贸区：医药研发企业的“靶向药”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ebb15e3037c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409770, encodeId=6ebb1409e70e8, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2018新浪医药年度总评榜十大榜单发布, objectType=article, longId=157281, objectId=411a15e28133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=411a15e28133, replyNumber=0, likeNumber=50, createdTime=2019-01-05, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=411a15e28133, moduleTitle=2018新浪医药年度总评榜十大榜单发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=411a15e28133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409769, encodeId=912d1409e69a2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=医药代表备案制来了！一旦“越界”将被列入“黑名单”, objectType=article, longId=157237, objectId=e18d15e23786, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e18d15e23786, replyNumber=0, likeNumber=55, createdTime=2019-01-05, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e18d15e23786, moduleTitle=医药代表备案制来了！一旦“越界”将被列入“黑名单”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e18d15e23786)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409768, encodeId=11051409e6811, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=德琪医药完成1.2亿美元B轮融资，发力肿瘤原研创新药平台布局, objectType=article, longId=157217, objectId=565415e2179e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=565415e2179e, replyNumber=0, likeNumber=63, createdTime=2019-01-04, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=565415e2179e, moduleTitle=德琪医药完成1.2亿美元B轮融资，发力肿瘤原研创新药平台布局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=565415e2179e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409767, encodeId=422e1409e6735, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=中国公民中医药健康文化素养水平呈上升趋势中医药养生保健成风尚, objectType=article, longId=157143, objectId=a0e215e143b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0e215e143b5, replyNumber=0, likeNumber=53, createdTime=2019-01-02, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0e215e143b5, moduleTitle=中国公民中医药健康文化素养水平呈上升趋势中医药养生保健成风尚, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0e215e143b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1409766, encodeId=08d11409e66ee, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=再鼎医药香港上市肿瘤电场治疗产品Optune, objectType=article, longId=157074, objectId=5c1f15e074f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c1f15e074f8, replyNumber=0, likeNumber=70, createdTime=2019-01-01, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c1f15e074f8, moduleTitle=再鼎医药香港上市肿瘤电场治疗产品Optune, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c1f15e074f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

医药

2020-05-29

cathymary (审核中...)

前往app查看评论内容

#医药#

2018年我国医药产品遭遇多起贸易摩擦

2019-01-25

cathymary (审核中...)

前往app查看评论内容

#医药#

国内医药巨头率先改革：下属代理商必须财税合规！

2019-01-25

cathymary (审核中...)

前往app查看评论内容

#医药#

医药健康类自媒体不能长“獠牙”

2019-01-24

cathymary (审核中...)

前往app查看评论内容

#医药#

保健品制售乱象后的医药中间体界定难题：致非法添加成潜规则

2019-01-23

仁者大医 (审核中...)

前往app查看评论内容

#医药#

盘点 | 2018年我国中医药重点产业政策

2019-01-23

cathymary (审核中...)

前往app查看评论内容

#医药#

“带量采购”搅动医药市场：冲击惯常销售模式，药价或大幅降

2019-01-21

cathymary (审核中...)

前往app查看评论内容

#医药#

60%老医药代表，已转行

2019-01-17

cathymary (审核中...)

前往app查看评论内容

#医药#

医药企业2018年政府补贴哪家强？

2019-01-16

cathymary (审核中...)

前往app查看评论内容

#医药#

为人民健康谋福祉医药改革让百姓更有获得感

2019-01-16

cathymary (审核中...)

前往app查看评论内容

#医药#

卫健委谈2019年工作：将推动中医药振兴发展

2019-01-13

cathymary (审核中...)

前往app查看评论内容

#医药#

亚盛医药多个核心品种获“十三五”国家“重大新药创制”科技重大专项支持

2019-01-13

cathymary (审核中...)

前往app查看评论内容

#医药#

2018年度国家科学技术奖揭晓医药卫生领域硕果累累

2019-01-12

cathymary (审核中...)

前往app查看评论内容

#医药#

和铂医药任命Atul Deshpande博士为首席战略官兼美国运营负责人

2019-01-08

cathymary (审核中...)

前往app查看评论内容

#医药#

荐读｜扑尔敏原料药企业实施垄断行为被处罚1243万元！医药代表备案制来了！

2019-01-06

cathymary (审核中...)

前往app查看评论内容

#医药#

上海自贸区：医药研发企业的“靶向药”

2019-01-06

cathymary (审核中...)

前往app查看评论内容

#医药#

2018新浪医药年度总评榜十大榜单发布

2019-01-05

cathymary (审核中...)

前往app查看评论内容

#医药#

医药代表备案制来了！一旦“越界”将被列入“黑名单”

2019-01-05

cathymary (审核中...)

前往app查看评论内容

#医药#

德琪医药完成1.2亿美元B轮融资，发力肿瘤原研创新药平台布局

2019-01-04

cathymary (审核中...)

前往app查看评论内容

#医药#

中国公民中医药健康文化素养水平呈上升趋势中医药养生保健成风尚

2019-01-02

cathymary (审核中...)

前往app查看评论内容

#医药#

再鼎医药香港上市肿瘤电场治疗产品Optune

2019-01-01

科室
- - 订阅+
  - 更多科室
工具
服务